GLP1R and diabetes mellitus: In the recent matched cohort study of patients with diabetes undergoing capsule endoscopy by Odah et al., the GLP-1 RA group had increased gastric transit time (99.3 ± 134.2 min vs. 25.3 ± 31.6 min, p < 0.001) and a greater rate of incomplete passage through the small intestine (23.5% vs. 4.4%, p < 0.01) as compared with the control group [42].